A leading consortium of industrial partners has been awarded a grant by the Seventh Framework Program of the European Union for an innovative research and development project “TA101 GOCLIN: Clinical development of TA-101 for the treatment of rheumatoid...
New patent granted to TechnoPhage/Lusomedicamenta Title: Antibacterial Phage, Phage Peptides and Methods of Use Thereof Office: United States Patent and Trademark Office Date: 22/10/2013 Patent no: US 8,563,504 B2
TechnoPhage invited to present Rheumatoid Arthritis therapeutics development programme at National Association of Rheumatoid Arthritis Patients (ANDAR) Symposium – “Disclosing the future in RA: the Portuguese contribution” at Gulbenkian Foundation,...
TechnoPhage invited to present at the National Symposium of Portuguese Association of the Pharmaceutical Industry – APIFARMA: “O Valor da Inovação: Da Investigação ao Doente” at Centro Cultural de Belém, Lisbon, Portugal. Seminar Title:...
